Targeted drug, radiotherapy could prolong life of liver cancer patients with resistance to immunotherapy, Hong Kong studies find
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Chinese University researchers say patients in trial took oral targeted therapy once a day and underwent scans every six weeks.